Tomas Hode, PhD, Co-Founder, CIO, and President of Immunophotonics will be attending the AngioDynamics International Life Symposium from March 27th to 29th in Barcelona, Spain. This symposium unites industry partners and clinical experts from around the world, featuring diverse backgrounds, skills, and ideas, all aimed at exploring the latest breakthrough technologies in interventional oncology. Be...
Lu Alleruzzo, CEO and Robert Arch, SVP Corporate Development at Immunophotonics, Inc. are attending the MedInvest Biotech and Pharma Investor conference which will be held on March 27 – 28, in New York City. Lu Alleruzzo and Robert Arch are presenting on March 27th at 12:25 pm. See how Immunophotonics is pioneering efforts that aim to...
Prof. Wei R. Chen, co-inventor of IP-001, Stephenson Chair, professor, and interim director of the Stephenson School of Biomedical Engineering recently chaired the international conference, “Biophotonics and Immune Responses XX,” at the Photonics West Symposium, sponsored by the International Society for Optics and Photonics (SPIE). This year marks the 20th anniversary of the Biophotonics and...
Robert Arch, SVP Corporate Development at Immunophotonics, Inc. will be attending the BIO CEO & Investor Conference which will be held on February 10 -11, 2025 in New York at the Marriott Marquis. This event is among the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. This conference presents an...
Tomas Hode, PhD, Co-Founder, CIO, and President of Immunophotonics, Inc. will be attending the SIO2025 Annual Scientific Meeting January 30 to February 3, 2025, in Las Vegas, Nevada. Tomas will be connecting with interventional oncology professionals from around the world on the latest developments in improving cancer care alongside medical, surgical and radiation oncology to...
Tomas Hode, PhD, President & CIO will attend the SPIE, the international society for optics and photonics conferences taking place from January 25 to 30 in San Francisco. This event is one of the largest gatherings focused on photonics technologies worldwide. Tomas is excited to explore the latest advancements in photothermal therapy and nanomaterials relevant...
Immunophotonics’ Tomas Hode, PhD (CIO and President) is attending Spectrum Conference, January 16 – 18, in Miami, Florida. Some of the leading experts in the field of interventional oncology will be sharing their insights on the latest advancements in the fight against cancer at this esteemed even. Tomas is excited to connect with such talented...
Our networking is well underway with investors and potential strategic partners for JPM2025 in San Francisco, January 13 – 16, 2025. Attending the annual summit Tomas Hode at JPM Healthcare Conference, Robert Arch at JPM Biotech Showcase, and Theresa Visarius at RESI. They are looking forward to fostering connections and to discussing our recent accomplishments...
Lu Alleruzzo, CEO and David Anderson, PhD, CSO of Immunophotonics, are excited to participate in the NCI SBIR Peer Learning and Networking (PLAN) webinar series. On Tuesday, November 19, from 3 PM to 4:30 PM (CST), they will share their insights and expertise in the session titled “CEO Perspectives on Launching & Growing Biotech Start-ups.”...
Immunophotonics co-founders Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President will attend the AngioDynamics International Life Symposium taking place November 7th to 9th in Monte Carlo. They will engage with industry partners and clinical experts globally, focusing on the latest breakthrough technologies for surgical interventions. Look for Lu and Tomas at this event...
